Table 2.
Cancer | miRNAs | Target | Refs. |
---|---|---|---|
Breast cancer | miR-10b | HOXD10, KLF4 | [235] |
miR-373 | Unknown | [230] | |
miR-200 family members | Unknown | [236] | |
miR-1246 | Unknown | [237] | |
Esophageal cancer | miR-21 | PDCD4 | [238] |
miR-93-5p | PTEN | [239] | |
Oral squamous cell carcinoma | miR-1246 | DENND2D | [240] |
Glioblastoma | miR-301a | Unknown | [241] |
miR-148a | CADM1 | [242] | |
Hepatocellular carcinoma | miR-665 | Unknown | [243] |
miR-125b | Unknown | [244] | |
miR-210 | SMAD4, STAT6 | [245] | |
miR-93 |
TP53INP1, TIMP2, CDKN1A |
[246] | |
miR-1247-3p | B4GALT3 | [247] | |
miR-103 | Unknown | [248] | |
Osteosarcoma | miR-675 | CALN1 | [249] |
Lung cancer | miR-17-3p, miR-21, miR-106a, miR-146, miR-155, miR-191, miR-192, miR-203, miR-205, miR-210, miR-212, miR-214 |
Unknown | [228] |
miR-21-5p, miR-126-3p, miR-140-5p |
Unknown | [250] | |
miR-193a-3p, miR-210-3p, miR-5100 |
Unknown | [251] | |
Ovarian cancer | miR-21, miR-141, miR-200a, miR-200b, miR-200c, miR-203, miR-205, miR-214 |
Unknown | [229] |
miR-99a-5p | Unknown | [252] | |
miR-375, miR-1307 | Unknown | [253] | |
Colorectal cancer | let-7a, miR-1229, miR-1246, miR-150, miR-21, miR-223, miR-23a |
Unknown | [231] |
miR-6803-5p | Unknown | [254] | |
miR-27a, miR-130a | Unknown | [255] | |
miR-25-3p | KLF2, KLF4 | [256] | |
Prostate cancer | miR-200c-3p, miR-21-5p, let-7a-5p |
Unknown | [232] |
Pancreatic cancer | miR-23b-3p | Unknown | [257] |
miR-191, miR-21, miR-451a |
Unknown | [258] | |
Gastric cancer | miR-423-5p | SUFU | [259] |
miR-23b | Unknown | [260] | |
miR-130a | C-MYB | [261] | |
miR-27a | Unknown | [262] | |
Acute myeloid leukemia | miR-125b | Unknown | [263] |
HOXD10, homeobox D10; KLF4, Krüppel-like factor 4; PDCD4, programmed cell death 4; PTEN, phosphatase and tensin homolog; DENND2D, DENN/MADD domain-containing 2D; CADM1, cell adhesion molecule 1; SMAD4, mothers against decapentaplegic homolog 4; STAT6, signal transducer and activator of transcription 6; TP53INP1, tumor protein p53-inducible nuclear protein 1; TIMP2, TIMP metallopeptidase inhibitor 2; CDKN1A, cyclin-dependent kinase inhibitor 1A; CALN1, calneuron-1; B4GALT3, β-1,4-galactosyltransferase 3; KLF2, Krüppel-like factor 2; SUFU, suppressor of fused homolog; C-MYB, v-myb avian myeloblastosis viral oncogene homolog.